Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06805799 · ClinicalTrials.gov registry record · NA

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

A NA study, sponsored by Lifespan.

Not yet
Registry status
NA
Development phase
40
Enrollment target

NCT06805799 is a NA study that has not yet begun recruiting, run by Lifespan. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06805799, a NA study, has not yet begun recruiting, sponsored by Lifespan.

NOT YET RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Prenatal Mindfulness training (MT) shows promise as a preventive intervention against hypertensive disorders of pregnancy (HDP) and may reduce risk for offspring cardiovascular disease (CVD). One proposed mechanism of MT to reduced CVD risk is improved self-regulation following stress. Perhaps the most crucial contributor to the development of self-regulation in the first year is the psychophysiological coregulatory relationship between mother and infant. However, this self-and co-regulation among women exposed to prenatal MT has not been studied and has yet to be examined in relation to CVD risk. The goal of this proposed project is to evaluate maternal-infant physiological reactivity to and recovery from stress at 6 months postpartum following prenatal MT, and to examine the relationship between these maternal infant stress responses and maternal-infant CVD risk at 12 months postpartum. Using a lab-based stress paradigm and well-validated biomarkers of mother and infant CVD risk, the investigators will assess respiratory sinus arrhythmia and heart rate at 6 months postpartum for 40 mother-infant dyads who have completed either prenatal MT or a usual care arm of an RCT examining MT for women at risk for HDP. The investigators will compare maternal, infant, and dyadic stress responses by treatment arm. Then, cardiac stress responses will be examined as predictors of maternal and infant biomarkers of CVD risk at 12 months postpartum.

Interventions

  • OTHER Follow up to Mindfulness RCT using a Still Face Paradigm

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-04-15
Est. Completion 2026-07-31
Phase NA

Sponsor

Lifespan

18 total trials

What the Registry Record Tells You About NCT06805799

The ClinicalTrials.gov registry entry for NCT06805799 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lifespan, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Follow up to Mindfulness RCT using a Still Face Paradigm is the first listed.

NCT06805799 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06805799 about?

NCT06805799 is a clinical study titled "Stress Reactivity and Mother-Infant Cardiovascular Disease Risk". Prenatal Mindfulness training (MT) shows promise as a preventive intervention against hypertensive disorders of pregnancy (HDP) and may reduce risk for offspring cardiovascular disease (CVD). One proposed mechanism of MT to reduced CVD risk is improved self-regulation following stress. Perhaps the m...

What is the current status of trial NCT06805799?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-04-15. Estimated completion is 2026-07-31.

What interventions are being tested in trial NCT06805799?

The interventions under investigation include: Follow up to Mindfulness RCT using a Still Face Paradigm (OTHER).

Who is sponsoring clinical trial NCT06805799?

This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.